Internal Medicine, Hematology & Oncology · Grand Rapids, MI
NPI
1003235391
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5800 Foremost Dr SE Ste 200
Grand Rapids, MI, 49546
Phone (616) 389-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
106,124 services
Medicare patients, 2024
401
Average age 71
Drug cost, 2024
$14.9M
3,286 prescriptions
Company payments, 2025
$580
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew L Sochacki was code J9144 (injection, daratumumab, 10 mg and hyaluronidase-fihj), 10,440 times for 15 patients. In total Andrew L Sochacki billed 106,124 services in 199 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-01.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,440 | 15 | $39.23 | $410K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,320 | 16 | $35.80 | $83K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,260 | 14 | $31.60 | $71K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 1,962 | 14 | $1.43 | $2,812 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,878 | 54 | $0.09 | $168 |
| 36415 Venipuncture Blood Collection | Office | 1,086 | 156 | $8.65 | $9,394 |
| 85025 Blood Count | Office | 1,076 | 154 | $7.61 | $8,188 |
| 80053 Clinical Chemistry | Office | 830 | 156 | $10.33 | $8,576 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 700 | 25 | $0.69 | $484 |
| 82784 Immunoassay | Office | 554 | 58 | $9.11 | $5,049 |
| 83615 Clinical Chemistry | Office | 425 | 133 | $5.89 | $2,505 |
| 96375 Injection Administration | Office | 415 | 76 | $10.86 | $4,505 |
| 83521 Immunoassay | Office | 354 | 40 | $16.93 | $5,991 |
| 99214 Office E&M - Established | Office | 329 | 153 | $89.33 | $29K |
| 88185 Surgical Pathology Examination | Office | 322 | 13 | $16.78 | $5,404 |
By year: 2022 $896K for 60,352 services; 2023 $1.0M for 76,840 services; 2024 $2.0M for 106,124 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,086 | 156 | $8.65 | $9,394 |
| 85025 Blood Count | 1,076 | 154 | $7.61 | $8,188 |
| 80053 Clinical Chemistry | 830 | 156 | $10.33 | $8,576 |
| 82784 Immunoassay | 554 | 58 | $9.11 | $5,049 |
| 83615 Clinical Chemistry | 425 | 133 | $5.89 | $2,505 |
| 83521 Immunoassay | 354 | 40 | $16.93 | $5,991 |
| 88185 Surgical Pathology Examination | 322 | 13 | $16.78 | $5,404 |
| 84550 Clinical Chemistry | 185 | 58 | $4.41 | $815 |
| 83735 Clinical Chemistry | 132 | 34 | $6.57 | $867 |
| 84165 Clinical Chemistry | 129 | 40 | $10.53 | $1,358 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew L Sochacki prescribed most often to Medicare patients was Acyclovir, with 600 prescriptions and refills. In total Andrew L Sochacki wrote 3,286 Medicare prescriptions that cost $14.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 600 | 770 | 130 | $9,482 |
| Dexamethasone Generic | 195 | 251 | 60 | $2,821 |
| Eliquis Apixaban | 188 | 215 | 28 | $120K |
| Revlimid Lenalidomide | 181 | 181 | 34 | $3.2M |
| Lenalidomide Generic | 165 | 165 | 20 | $2.4M |
| Calquence Acalabrutinib Maleate | 128 | 128 | 18 | $1.7M |
| Imbruvica Ibrutinib | 116 | 116 | 11 | $1.7M |
| Venclexta Venetoclax | 108 | 108 | 27 | $996K |
| Prochlorperazine Maleate Generic | 105 | 112 | 62 | $1,924 |
| Prednisone Generic | 98 | 115 | 39 | $324 |
| Pantoprazole Sodium Generic | 93 | 155 | 31 | $1,156 |
| Levothyroxine Sodium Generic | 62 | 96 | 14 | $565 |
| Hydroxyurea Generic | 60 | 90 | 13 | $1,236 |
| Ondansetron Hcl Generic | 56 | 56 | 27 | $600 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 72 | 19 | $189 |
Brand drugs: 1,121 claims; generic drugs: 2,165 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew L Sochacki $580 ($418 in general payments such as food, travel and fees and $163 for research) from 18 companies. The largest payer was Servier Pharmaceuticals LLC with $104.
| Company | Payments | Amount |
|---|---|---|
| Servier Pharmaceuticals LLC | 1 | $104 |
| Genzyme Corporation SNY | 3 | $78.83 |
| Abbvie Inc. ABBV | 1 | $59.04 |
| Daiichi Sankyo Inc. 4568.T | 2 | $46.49 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $45.9 |
| Janssen Biotech, Inc. JNJ | 1 | $42.61 |
| Pfizer Inc. PFE | 2 | $33.56 |
| TerSera Therapeutics LLC | 1 | $31.22 |
| Merck Sharp & Dohme LLC MRK | 1 | $30.76 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.